Best Compounded Semaglutide Pharmacy 2026, Patient-Ranked

By the GLP-1 US editorial team · Last reviewed: May 23, 2026 · About our review process

In May 2026, a Washington pharmacy that compounded semaglutide for one of the biggest US telehealth brands was forced to close after whistleblowers reported untrained day laborers handling sterile vials. Most patients did not know the pharmacy’s name. Most did not know their program had a pharmacy partner at all.

That gap is what every other “best compounded semaglutide pharmacy” article ignores. They rank by dollars per month and stop there. The best compounded semaglutide pharmacy is not the cheapest one. It is the one that names its 503A partner, ships during dose escalation without making you re-intake, and refunds you when something goes wrong.

The seven providers below are ordered by patient experience under the FDA’s April 2026 rules: 503A pharmacies only, four-prescriptions-per-month safe harbor, three eligibility pathways. We sampled intake flows, cold-chain packaging, refund processes, and pharmacy disclosure pages. Five providers we considered are in the skip callout below, including the one that lost its compounding partner this spring.

How We Ranked These Pharmacies (and Which Providers to Skip Outright)

Zero of the major compounded semaglutide telehealth providers publicly state whether their semaglutide is the FDA-recognized base form or one of the unapproved sodium or acetate salts. Not Hims. Not Henry Meds. Not Mochi. Not Eden. That industry-wide blind spot, flagged in the policylab.us transparency audit, is why this list ranks on what providers actually do disclose: pharmacy, price, refill rules, refund path.

Our seven ranking criteria:

Pharmacy partner disclosure. Does the provider publicly name the 503A pharmacy filling your prescription? Foley & Lardner’s April 2026 analysis flagged undisclosed pharmacies as continuity and misbranding risks.
503A status under the April 2026 FDA rules. Four-prescriptions-per-month safe harbor at any single 503A pharmacy, three eligibility pathways (allergy to an inactive ingredient in Wegovy or Ozempic, dose strength not commercially available, different delivery route).
Time to first shipment.
Refill workflow during dose escalation. Does titration trigger a new intake form, or does the clinician update the prescription directly?
Clinician response SLA. Hours, not days, to reply to a side-effect message.
Refund-process lived experience. Does the provider honor refunds or stall with friction?
Pricing transparency before signup. Can you see the price before submitting personal info?

On April 1, 2026, the FDA clarified that a 503A compounder is safe from enforcement on the “essentially a copy” standard if it fills four or fewer prescriptions per calendar month of a compounded version of Wegovy or Ozempic. Larger volumes require documented clinical need under one of the three pathways. On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List (91 Fed. Reg. 23431), with public comment closing June 30, 2026. That proposal targets 503B outsourcing facilities, not 503A patient-specific compounding, which is the route every provider in this ranking uses.

Five providers we considered and excluded:

Mochi Health. Partner pharmacy Aequita (Kirkland, WA) shut down in early May 2026 after Washington DOH enforcement and whistleblower reports of untrained day laborers handling sterile vials. Mochi diversified to pharmacies it will not name.
Hims & Hers. Novo Nordisk sued on February 9, 2026 alleging “inauthentic API,” with independent testing reporting impurity up to 86% in injectables and 75% in oral. FDA warning letters in September 2025.
Boothwyn-sourced orders. Boothwyn Pharmacy LLC received an FDA warning letter dated January 16, 2026: semaglutide at 79.9% potency, tirzepatide that failed sterility and was distributed anyway. Eden and ShedRx both list Boothwyn. Confirm in writing which partner is shipping your batch.
IVYRx. Markets pharmacies as “503B / USP <797>” when the confirmed partner (Greenwich RX) is 503A. The exact misbranding mismatch Foley & Lardner flagged.
Lemonaid Health. The only documented cold-chain failure in our prior audit, with a $348 median monthly cost (highest in the category).

Top Picks Comparison Table

Provider	Best For	Starting Price	Patient-First Score	Apply Now
Goby Meds	The Transparency Standard for First-Time Semaglutide Buyers	$169/mo	78 / 100	See Offer
Pomegranate	Cheapest Named-Pharmacy Semaglutide in the Category	$119/mo	86 / 100	See Offer
Eden	The Only Provider Naming Every 503A Pharmacy Partner	$149/mo	87 / 100	See Offer
OnlineSemaglutide.org	Four Named 503A Pharmacies, One Big Review-Credibility Problem	$259/mo	93 / 100	See Offer
ShedRx	Strongest Refund Guarantee, Best Cold-Chain Packaging	$199/mo	98 / 100	See Offer
Henry Meds	Cheapest Microdose Semaglutide and Proactive Nausea Care	$297/mo	96 / 100	See Offer
Enhance.MD	Real Clinical Oversight, Real Cancellation Friction	$249/mo	91 / 100	See Offer

1. GobyMeds: The Transparency Standard for First-Time Semaglutide Buyers

GobyMeds is the only provider in this list where you can pull up the pricing tab, pick the pharmacy and the additive (B12, B6, niacinamide), see the flat monthly cost, and decide whether to start. You do all of that before submitting an email address.

Pricing: $169/month for compounded semaglutide injection, flat across all doses. $299 for three months at the lowest tier, $399 for 0.2 to 1.0 mg, $499 for 1.2 to 2.3 mg. No membership fee. Non-subscription: never auto-charged.

Pharmacy partners: CasaPharmaRx (License #34595, nine compliance deficiencies in August 2025 all corrected by January 2026), SevenCells (also operating as Performance Wellness Pharmacy, three Florida locations all clear), VitalRx (Pearland TX, active license, no disciplinary actions), and BPI Labs (Largo FL, clear). All four pharmacy names plus the additive are displayed at intake with hover tooltips. 503A status.

Patient-experience strengths:

Pharmacy and additive visible at intake. Only provider in this audit with that UX.
Flat $169 per month regardless of dose. Eliminates the dose-escalation sticker shock that hits other programs at week 8.
8-stage portal order tracker: order placed, care team review, medical consultation, prescription received, at pharmacy, shipped, delivered.
24 hours from shipment dispatch to delivery once it leaves the warehouse. Fastest observed in our review.
LegitScript certified. Trustpilot 4.5. BBB B+.
Non-subscription: you reorder when you want.
HSA and FSA accepted.

Patient-experience weaknesses:

Phone support is non-functional. Automated “we are busy” voicemail with no callbacks.
Chat replies arrive via email with a 1 to 2 day turnaround. The single biggest friction point.
Refill workflow is not documented in the portal. You message support to learn that the order window opens two weeks before run-out.
Intake requires a full-body photo in tight clothes. Reviewer flagged this as invasive.
No salt-form disclosure (industry-wide gap).

Best for: First-time buyers who want pharmacy and price visible before they commit, switchers leaving a subscription-locked program, and anyone who needs flat pricing through the full semaglutide dose escalation.

Skip if: You need synchronous phone or same-day chat support. GobyMeds is async to the bone.

Intake: my.gobymeds.com/register.

2. Pomegranate Health: Cheapest Named-Pharmacy Semaglutide in the Category

Pomegranate scored 94 out of 100 in our underlying audit, the highest of any compounded semaglutide provider. So why isn’t it ranked first? The audit is not the patient experience. Once you are a patient, Pomegranate is excellent. Getting to that point is the problem.

Pricing: $119/month for compounded semaglutide starter from Empower (with B12) or Hallandale (no additive). $139/month for advanced doses. The 6-month Empower bundle drops to $499 ($83/month). A $150 administrative fee applies to specify a pharmacy. Tirzepatide starts at $179/month from BPI Labs.

Pharmacy partners (all named publicly): BPI Labs, Empower Pharmacy, Hallandale Health, RedRock Pharmacy, OptioRx. Most have clean disciplinary records. Two RedRock locations carry minor resolved citations (Springville $750 and $1,050, Salt Lake City $500 for aiding unlicensed practice). Empower operates both 503A and 503B; the 503A side fills Pomegranate prescriptions.

Patient-experience strengths:

Most transparent pricing tool in the category. Interactive tab lets you compare by pharmacy and dose before signup.
Cold-chain shipping is best-in-class: two large non-sweat ice packs, tight foam wrap, vial jammed between packs inside a pill bottle inside a ziplock.
Monthly phone check-in appointments. Most semaglutide telehealth skips this synchronous touchpoint.
Non-subscription: never auto-charged.
LegitScript certified. HIPAA notice on its own footer page.
24-hour prescribing turnaround after consult. All 50 states.

Patient-experience weaknesses (lead with these):

Non-patient pre-purchase support is a loop. Reviewer quote: “If you are not currently a patient you might find that you are sent on a loop trying to contact support and coming up unsupported.”
BBB F rating. Eight complaints, failure to respond to six.
Trustpilot 3.4 across 114 reviews.
Zero refunds on membership, consults, or medications (filled or not).
24-hour window to report pharmacy or delivery issues.
Portal runs on CharmHealth: dated, slow, no shipping tracking or receipts in-portal.
Chat response 12 to 24 hours. Phone goes to voicemail.
$25 cancellation fee inside the 24-hour window. $100 chargeback fee for disputes Pomegranate considers frivolous.

The cheapest legitimate compounded semaglutide in the category is also the one with the worst pre-purchase support. If you can get through intake without needing help, Pomegranate’s ongoing clinical experience is excellent and the pharmacy network is the most transparent in this list. If you need anyone to walk you through anything before paying, go to GobyMeds and pay the $50/month delta.

3. Eden: The Only Provider Naming Every 503A Pharmacy Partner

Eden is the only telehealth brand in this list that publishes every pharmacy partner by name on its FAQ page. It also acquired Contigo Compounding in August 2025 to operate one partner in-house. That single act of disclosure puts Eden ahead of every provider in the next 100 Google results for compounded semaglutide.

Pricing: $149 first month, $229/month recurring for compounded semaglutide injection (price updated April 2026 from $249). $129 first month plus a $209 three-month bundle option. Compounded tirzepatide: $299 first month, $349/month thereafter. Brand-name Wegovy $1,695/month with no membership fee, which is rare.

Pharmacy partners (fully named): GoGoMeds, Precision Pharmacy, Enovex (PCAB-accredited through ACHC, the only PCAB partner), and AbsolutePharmacy. Boothwyn is also listed and is the one to flag. Boothwyn received an FDA warning letter dated January 16, 2026 with 79.9% semaglutide potency and a tirzepatide sterility failure. Confirm with Eden support which partner fills your order before each shipment. Plus Eden’s in-house 503A via Contigo Compounding.

Patient-experience strengths:

Names every pharmacy partner publicly. Only major provider doing this.
In-house 503A via Contigo Compounding.
Overnight shipping once prescription fills.
Same-day async approval during business hours.
One-button portal cancellation, immediate effect, no charges after cancel.
Tracking visible in email and portal.
Trustpilot 4.4. HSA, FSA, and brand-name insurance accepted on Wegovy.

Patient-experience weaknesses:

BBB F rating. 90 complaints over three years, 67 reportedly unanswered.
Boothwyn warning letter is open. Verify your specific pharmacy at each shipment.
Marketing vs checkout price discrepancy: reviewer-confirmed $20 to $30 gap during the April 2026 pricing transition.
Prepaid-plan cancellation friction documented on Trustpilot and BBB.
HIPAA notice could not be located in privacy policy or TOS.
No clear provider name shown to patient. Only a cartoon icon.
Not available in AR, LA, MS, or NM (46-state coverage).

If transparency on which 503A pharmacy fills your prescription matters to you, and you can tolerate the BBB-complaint risk profile, Eden is the strongest pharmacy-disclosure pick in the ranked roster. Before each refill, message support and confirm which named partner is shipping your batch. That is the Boothwyn warning letter making it concrete.

4. OnlineSemaglutide.org: Four Named 503A Pharmacies, One Big Review-Credibility Problem

OnlineSemaglutide.org names all four of its pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx). Policylab.us scored that disclosure 9.4 out of 10. It also has a Trustpilot rating of 0 stars, no BBB profile, and on-site testimonials that previously recycled the same stock images under different names.

Pricing: $259/month semaglutide injection. $500 for three months ($167/month). $900 for six months ($150/month), paid upfront. Compounded tirzepatide $349/month, $800 for three months, $1,450 for six. Oral drops $249 to $399. Brand-name Wegovy $990/month.

Pharmacy partners (one PCAB): Belmar Pharmacy (Florida community plus sterile licenses, no discipline; Connecticut nonresident active; Colorado closed due to ownership change). Strive Pharmacy (multiple locations; Arizona consent agreement on semaglutide compounding with a $1,000 civil penalty in 2024; PCAB-accredited through ACHC). Epiq Scripts (Richardson TX, closed-door non-sterile). Casa Pharma Rx (Stafford TX, closed-door sterile, low/medium/high-risk authorized). Patient cannot select which pharmacy fills the order.

Patient-experience strengths:

All four pharmacy partners named with contact info. Policylab scored 9.4 out of 10 for transparency.
Strive holds PCAB accreditation through ACHC.
Cleanly named prescribing providers: Dr. HirenKimar Italia (NPI 1487815387) and Dr. Ana Lisa Carr (NPI 1689841744). Both verifiable.
2-day shipping with tracking via email.
Async monthly follow-ups.
LegitScript certified, HIPAA notice present, US clinic address verifiable in San Diego CA.

Patient-experience weaknesses (lead with these):

Review credibility is the worst in the list. Trustpilot 0 stars, no BBB profile, on-site reviews previously used stock images with different names. The site removed the faces but still does not link to verifiable third-party reviews.
“Certain states” served. The actual state list requires emailing customer service.
Cancellation friction. Documented flow: 1/25/2026 email to cancel, 1/26 confirmation, then a 1/29 follow-up saying “cancellation is being processed.” Multiple touches required.
Pricing is bundle-skewed. The $150/month figure is actually $900 paid upfront for six months.
Patient cannot select pharmacy. Disclosure is informational, not selection-enabling.
No salt-form disclosure.

Best for: The pharmacy-disclosure maximalist who values four named 503A partners over Trustpilot reviews and is comfortable with bundle pricing.

Skip if: Verifiable third-party reviews are a deal-breaker, or you want to pick your specific pharmacy.

5. ShedRx: Strongest Refund Guarantee, Best Cold-Chain Packaging

ShedRx ships with three gel ice packs inside an insulated foam box, double-bagged in bubble wrap. It is also the only provider with a contractual refund clause: lose at least 10% body weight in the program or get a full refund.

Pricing: $199 first dose, $299/month recurring for compounded semaglutide injection (price escalates by dose). Microdose semaglutide $149/month flat. Oral lozenges $199 first dose then $299/month. Oral drops $299 first dose then $326/month. Oral liposomal tablets $299/month. 2-month minimum commitment.

Pharmacy partners (updated March 2026): Strive, Boothwyn (the FDA-warning pharmacy, flag this), WP Pharma Labs, Red Rock, Promise, Everwell Specialty, Foothills Professional. Wide network, real supply redundancy. Several partners carry past resolved citations (Strive Arizona’s $1,000 consent agreement, Promise Florida’s sterile compounding oversight, RedRock’s minor citations). Boothwyn’s January 2026 warning letter is the one to ask support about.

Patient-experience strengths:

Strongest contractual refund clause in the category: 10% weight loss or full refund.
Cold-chain packaging the best we reviewed: 3 ice packs plus foam plus bubble-wrap envelope.
Overnight shipping standard. Tracking in both email and patient portal.
Most format variety: injections, lozenges, drops, liposomal tablets, microdose semaglutide ($149/month), microdose tirzepatide ($199/month), plus brand-name Wegovy and Zepbound.
AI phone support with a human reachable on request.
Video consultation schedulable in-portal.
150,000+ active members.

Patient-experience weaknesses (lead with these):

2-month minimum commitment buried in checkout fine print. No refunds in that window unless the 10% threshold is met.
Pricing not visible until intake completion. Only “starting at $199” appears on the main medication page.
Price escalates by dose, unlike GobyMeds flat $169.
LegitScript status is Probationary, not full certification.
Boothwyn in the partner network. Confirm which partner fills your order before each ship.
Video consultation required. Adds about a day to time-to-first-shipment.
Consult quality flagged. Master-sheet review noted misinformation about pairing intermittent fasting and keto with GLP-1s.

If you want to microdose semaglutide ($149/month) or you want the only refund clause in the category that actually returns your money, ShedRx is the deepest program at the price. Lock in the two-month commitment knowingly, and request anything but Boothwyn while their warning letter is open.

6. Henry Meds: Cheapest Microdose Semaglutide and Proactive Nausea Care

Henry Meds is the only provider in this audit that ships ondansetron (the anti-nausea medication) with every order. No extra prescription, no separate pickup. For a first-time semaglutide patient where nausea is what is making them hesitate, that single inclusion changes the math.

Pricing: $297/month for compounded semaglutide injection at the standard dose. $99/month for microdose semaglutide injection, the lowest legitimate microdose in the category. $1,482 for six months, $2,364 for twelve months. Oral semaglutide tablets $297 per three-month bundle. Oral tirzepatide $597 per three-month bundle. Liraglutide $99/month.

Pharmacy partner: Tailor Made Compounding LLC. Tailor Made’s Kentucky permit (#P07728, Nicholasville) expired March 3, 2021. The Kentucky Board of Pharmacy Agreed Order in Case 21-0193A (June 15, 2022) followed a federal plea agreement for unlawful interstate distribution of bulk compounded drugs. The pharmacy was fined $5,000 and agreed never to reopen under a Kentucky permit. Whether Henry Meds continues to use Tailor Made or has rotated could not be verified. Third-party reviews name Hallandale and Hephaestus as historical partners. Ask in writing which pharmacy is filling your prescription before ordering.

Patient-experience strengths:

Ondansetron included in every box by default. Unique in the category.
2-day shipping with two ice packs in thick insulated foam and cotton-ball vial stabilization.
Injection guide plus syringe how-to card included in shipment.
Board-certified health coach auto-assigned, bookable 1-on-1 in portal.
Async or synchronous consult, patient’s choice at intake.
All 50 states. LegitScript certified, HIPAA compliant.
4.5 Trustpilot across 12,000+ reviews. Largest review base in this list.

Patient-experience weaknesses (lead with these):

Pricing UX is broken. Refreshing the medication selection page yields different results each session.
$297 standard semaglutide is expensive next to GobyMeds $169 or Pomegranate $119.
Pharmacy partner history requires reader due diligence (above).
BBB F rating driven by auto-renewal and cancellation complaints.
Documented undisclosed pharmacy switches. One patient paid $2,694 for a bulk order; the second batch was “completely ineffective” and Henry refused a refund citing “all sales final.”
Countdown timers in checkout flagged as pressure tactics.
One-week wait for the initial clinician appointment.

Best for: First-time patients nervous about nausea, and microdosers chasing the cheapest entry-level price ($99/month). Confirm the pharmacy in writing before paying.

Skip if: Pricing transparency is non-negotiable, or you want a refund path for bulk orders that do not work.

7. Enhance.MD: Real Clinical Oversight, Real Cancellation Friction

Enhance.MD‘s portal has a large, prominent “Cancel” button. Click it and you get a message: it is necessary to speak with a customer service representative or medical assistant to finalize the closure of your medical chart. The button is a phone-call trap, and it is the reason Enhance.MD ranks here instead of higher.

Pricing: $249/month for compounded semaglutide (all doses same price, no dose-escalation surcharge). $329/month for compounded tirzepatide. Month-to-month.

Pharmacy partners: Rite-Away Pharmacy, Vios Compounding Pharmacy, TruMedsRx. No disciplinary history across all three. 100 out of 100 Legitimacy sub-score in our review.

Patient-experience strengths:

Lab work required before month 2, then every 6 months. Only provider in the ranked roster with mandatory clinical oversight.
Phone support answered by real humans 8 a.m. to 8 p.m. EST. No AI gating.
Chat responds in minutes.
FedEx Standard Overnight shipping. Cold-chain solid: foam insulation, one large sweat-proof ice pack.
1-on-1 nutrition and fitness coaching schedulable in portal.
Patient and provider both listed with name and credentials.
Trustpilot 4.1. BBB A+. Flat $249 across all doses.
94 out of 100 total audit score, second-highest in the ranked roster.

Patient-experience weaknesses (lead with these):

Cancellation deception: large “Cancel” button routes to a mandatory phone call.
Not available in 10 states: AL, AR, GA, HI, LA, MS, MO, SC, TN, WV.
Lab work adds friction before month 2.
No injection instructions or drug information in the shipment box. Master sheet flagged this as the riskiest information gap for first-time injectors.
HSA and FSA not accepted.
Video consultation required (20-minute initial). Adds about a day to first ship.
No semaglutide microdose option (unlike Henry Meds $99/month or ShedRx $149/month).

Best for: Patients who want labs, coaching, and real clinical oversight, who plan to stay on semaglutide long-term, and who live in a covered state.

Skip if: You shop providers expecting to leave when something better comes along, or you want microdose semaglutide. The cancel button is not really a button.

The Bottom Line: Which Compounded Semaglutide Pharmacy Is Right for You

Seven providers. Not one is right for every buyer. Pick by what matters most to you.

Cheapest legitimate named-pharmacy semaglutide: Pomegranate Health ($119/month starter, five named pharmacies). Be ready to navigate pre-purchase support yourself.
First-time buyers nervous about nausea: Henry Meds (ondansetron in every box). Confirm pharmacy partner in writing before paying.
Refill reliability and pharmacy transparency: GobyMeds (four named 503A partners, flat $169/month, pharmacy visible at intake).
Pharmacy disclosure as #1 signal: Eden (every partner named publicly plus in-house Contigo 503A) or OnlineSemaglutide.org (four named partners, Strive holds PCAB) if you can tolerate the review gap.
Fastest shipment-to-door: Eden (overnight) or ShedRx (overnight, strongest cold-chain packaging).
Strongest refund insurance: ShedRx (10% body weight loss or full refund, the only contractual refund clause).
Microdose semaglutide: Henry Meds ($99/month, cheapest) or ShedRx ($149/month, broader format variety).
Real clinical oversight: Enhance.MD (labs required, coaching, BBB A+). Know the cancel button is a phone call.

The FDA’s April 30, 2026 proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List has a public comment period closing June 30, 2026. 503A patient-specific compounding, the route every provider in this list uses, is not affected. The providers that name their 503A pharmacy today will be easier to verify and transition with tomorrow.

Price is one column. Pharmacy disclosure, refill workflow, refund reality, and clinical oversight are the other four. Pick the provider whose patient experience matches yours.

Frequently Asked Questions

Is compounded semaglutide still legal in 2026?

Yes, but under narrower rules than during the shortage. 503A pharmacies can still compound semaglutide for individual patients with documented clinical need under one of three FDA-recognized pathways: allergy to an inactive ingredient in Wegovy or Ozempic, a dose strength not commercially available, or a different delivery route needed. The four-prescriptions-per-month safe harbor adds buffer for small-volume 503A pharmacies. 503B outsourcing facilities can no longer compound semaglutide except during a declared shortage.

What is the FDA’s four-prescriptions-per-month rule for compounded semaglutide?

A 503A pharmacy is safe from FDA enforcement on the “essentially a copy” standard if it fills four or fewer prescriptions per calendar month of a compounded drug that closely matches a commercial product. For larger volumes, the prescriber must document individual clinical need under one of the three eligibility pathways. Telehealth platforms with thousands of semaglutide patients cannot rely on the four-per-month safe harbor alone. They need documented clinical need for each patient.

Semaglutide base vs sodium or acetate salt, does it matter?

Yes, and zero of the major telehealth providers publicly confirm which form they use. The FDA-approved semaglutide in Wegovy and Ozempic is the base form. Semaglutide sodium and semaglutide acetate are different active ingredients, and the FDA has stated it is not aware of any basis for compounding from these salt forms. Ask your provider explicitly, in writing, before ordering.

What happens if the FDA finalizes the 503B Bulks List exclusion?

503A pharmacies, which fill prescriptions for every provider in this ranking, are not affected by the proposal. The FDA’s April 30, 2026 proposal (91 Fed. Reg. 23431) would exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, with the public comment period closing June 30, 2026. If finalized, 503B outsourcing facilities can no longer compound these drugs from bulk API except during a declared shortage. Patients using 503A-based telehealth programs are not directly affected.

How do I verify my compounding pharmacy is legitimate?

Five-step verification. Ask the telehealth provider in writing for the pharmacy name and address. Confirm an active, unrestricted license on the state board of pharmacy website. Check the NABP Disciplinary Actions database at nabp.pharmacy/disciplinaryactions. Verify PCAB or ACHC accreditation at pcab.org or achc.org. Request a Certificate of Analysis with HPLC purity above 95%, potency within 10% of label, sterility pass, and endotoxin within USP limits. If your provider refuses any of these, treat it as disqualifying.

Can I switch compounded semaglutide providers without restarting my dose?

Usually yes, if you bring your prescription records. Standard semaglutide titration runs 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg at four-week intervals, and a new provider may not have your dosing history unless you provide it. Bring your prior prescription documentation, request a copy of your previous prescription before canceling the old program, and confirm with the new prescriber that they will continue at your current maintenance dose.

Should I switch from compounded semaglutide to Foundayo (orforglipron)?

Foundayo is worth evaluating if you prefer oral delivery, have commercial insurance (the savings card brings it to $25/month), or have cold-chain concerns about shipped injectables. Eli Lilly’s orforglipron was FDA-approved on April 1, 2026 at $149/month self-pay (lowest dose), and $50/month on Medicare Part D from July 2026. It is a different molecule than semaglutide, so clinical response may differ. Talk with your prescriber before switching mid-treatment.